Z-0883-2022 Class II Ongoing

Recalled by Abbott Molecular, Inc. — Des Plaines, IL

FDA device recall Z-0883-2022 was initiated by Abbott Molecular, Inc. on Mar 4, 2022 and is designated Class II. Reason for recall: There is a potential for misquantitation high results of negative samples. The recall status is ongoing.

Recall details

Product Type
Devices
Report Date
Apr 13, 2022
Initiation Date
Mar 4, 2022
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Alinity m HBV Application Specification File (US and CE)

Reason for recall

There is a potential for misquantitation high results of negative samples.

Distribution pattern

US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam

Code information

List Numbers: 1) 08N47-03A (US); Version 1.00 2) 08N47-01B (CE); Version 2.00 3) 08N47-01C (CE); Version 3.00

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0883-2022
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Abbott Molecular, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0883-2022. Report a data issue: hello@regdatalab.com.